NRX Pharmaceuticals Inc (STU:B1Q)
€ 4.88 0 (0%) Market Cap: 42.04 Mil Enterprise Value: 46.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

NRX Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Dec 19, 2023 / 04:00PM GMT
Release Date Price: €3.8 (-4.52%)
Stephen Willard
NRX Pharmaceuticals Inc - Chief Executive Officer

Good morning, ladies and gentlemen, and welcome to the Annual Meeting of Stockholders of NRx Pharmaceuticals, Inc. I'm Stephen Willard, Chief Executive Officer of NRx and I'm very happy to be with you today. Thank you for joining us. I will be assisted in today's meeting by our Chief Financial Officer, Richard Narita, and by Dr. Jonathan Javitt, the founder of our company we will begin today with the formal part of the program during which we will ask the shareholders to one telephony tenant request as a Class two members of the company's Board of Directors to approve a proposed amendment to the company's 2021 Omnibus Incentive Plan to increase the maximum number of shares of common stock available for issuance under the plan three, ratify the selection of Solberg & Company PA as the company's independent auditors for the fiscal year ended December 31, 2023, four, approve on an advisory basis, the compensation of our named executive officers as set forth in the company's proxy statement and five approve on an advisory basis, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot